Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/11/2011
PIL Viracept Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/09/2011 and displayed until 21/11/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 09/06/2011 and displayed until 15/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 29/01/2010 and displayed until 09/06/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 08/08/2008 and displayed until 29/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
Updated on 18/07/2008 and displayed until 08/08/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/04/2008 and displayed until 18/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 23/01/2008 and displayed until 08/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
Updated on 05/11/2007 and displayed until 23/01/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to warnings or special precautions for use
Updated on 18/07/2007 and displayed until 05/11/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 23/01/2007 and displayed until 18/07/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 04/07/2006 and displayed until 23/01/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/06/2006 and displayed until 04/07/2006
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 15/03/2006 and displayed until 09/06/2006
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 16/06/2005 and displayed until 15/03/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change from BAN to rINN
Updated on 24/02/2005 and displayed until 16/06/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
Updated on 28/04/2004 and displayed until 24/02/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
Updated on 16/12/2003 and displayed until 28/04/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  nelfinavir mesilate